By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Quality of Life in Alzheimer Disease: QOL-AD
Summary
What it measures:
The QOL-AD is a 13-item questionnaire designed to provide both a patient and a caregiver report of the quality of life (QOL) for patients who have been diagnosed with Alzheimer Disease (AD) (Logsdon, Bibbons, McCurry, & Teri, 1999).
The 15-item QOL-AD includes an additional four items, including the ability to take care of oneself, live with others, make own life choices, and people who work within the residential setting (Edelman, Fulton, Kuhn, and Chang, 2005). Two items related to money and marriage were eliminated to better represent people living in a residential setting. Wording was changed in three items from “self as a whole” to “self-overall,” and “ability to do chores” to “ability to be busy,” and “life as a whole” to “life overall.” Items on this adapted QOL-AD are rated by residents with the original 4-point scale (poor, fair, good, excellent).
Target Population:
This summary contains information on the QOL-AD in patients or clients with AD
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: June 29, 2017
Contact: practice@apta.org
Content Type: Test & Measure
Rania Karim, PT, DPT Board-Certified in Geriatric Physical Therapy
You Might Also Like...
CPG
Dementia: Assessment, Management and Support for People Living With Dementia and Their Carers [NG97]Dec 16, 2020
This guideline provides recommendations related to diagnosis and management of patients with dementia.
Clinical Summary
DementiaMay 29, 2017
PTs work with patients with dementia to address mobility and strength limitations, minimize fall risk factors, and enhance the patient’s quality of life.
CPG
Recommendations on Screening for Cognitive Impairment in Older AdultsJan 5, 2016
Recommendations on screening for cognitive impairment in adults with a focus on assessing asymptomatic adults.